查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080363

替代和補充醫學市場：2026-2032年全球市場預測（按治療方法、疾病、最終用戶和分銷管道分類）

Alternative & Complementary Medicine Market by Therapy Type, Disease Indication, End-User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，替代和補充醫學市場將成長至 5,188 億美元，複合年成長率為 13.33%。

主要市場統計數據
基準年 2025 2159.5億美元
預計年份：2026年 2442.2億美元
預測年份 2032 5188億美元
複合年成長率 (%) 13.33%

執行摘要：替代和補充醫學市場展望

替代和補充醫學正從一種與健康相關的範疇，逐漸轉變為預防醫學、慢性病支持、疼痛管理、復健和心理健康策略中更為正式的一部分。這種需求的促進因素包括人口老化、非傳染性疾病負擔日益加重、消費者對整體護理的偏好不斷增強，以及人們對針灸、脊椎按摩療法、阿脊骨神經醫學、草藥、自然療法、冥想、瑜伽、按摩療法、整骨療法和傳統中醫等療法的更廣泛了解。

替代和補充醫學領域的變革性變化

實證健康理念、以病人為中心的照護以及傳統醫學與輔助療法的融合正在改變這個領域。醫療保健系統正在選擇性地將針灸、正念療法、瑜伽、脊椎按摩療法、脊骨神經醫學和按摩等療法納入其中，尤其是在疼痛、壓力、睡眠、康復、肌肉骨骼疾病和提高生活品質等領域，前提是這些療法的有效性得到臨床證據的支持。

人工智慧對輔助醫學的累積影響

人工智慧正透過改善個人化醫療、實證醫學、供應鏈可追溯性、品管和消費者互動，在替代和補充醫學領域產生日益累積的影響。在適當的臨床管治下，人工智慧工具可以輔助症狀分流、生活方式指導、治療依從性、數位化治療、醫護人員工作流程，並識別患者報告結果、穿戴式裝置數據和電子健康記錄中的模式。

亞太地區、北美地區、歐洲地區、拉丁美洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區仍然是基礎區域，中國、印度、日本、韓國、澳洲和東協市場將悠久的醫療傳統與不斷發展的數位醫療基礎設施和官方政策認可相結合。傳統中醫、阿育吠陀、草藥、瑜伽、針灸、草藥產品和身心療法受益於文化上的認可、與特定醫療保健系統公共部門的融合、從業人員培訓計劃以及面向出口的生產能力。

對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約市場的關鍵群體分析

東協市場正透過草藥產品、養生旅遊、傳統療法、數位商務以及中產階級醫療費用支出的成長而日益重要。同時，海灣合作理事會（GCC）的高階養生診所、預防保健項目、長壽支持服務以及與醫療旅遊相關的資產正在蓬勃發展，這與各國醫療保健轉型議程相契合。歐盟的特點是嚴格的產品品質標準、安全文件要求、廣告標準以及統一的跨境法規，這有利於那些擁有完善合規體系和檢驗供應鏈的企業。

針對主要替代和補充醫學市場的國家/地區特定洞察

美國在消費者接受輔助療法方面處於主導，國家健康訪問調查的數據顯示，瑜伽、冥想、脊骨神經醫學療法、按摩療法、自然療法和針灸在成年人中廣泛使用。在加拿大，受監管的天然保健產品、多個省份的專家監督以及消費者對預防性保健的濃厚興趣是關鍵因素。同時，墨西哥和巴西則將傳統草藥療法、社區治療、不斷成長的健康零售市場以及對私人醫療保健的需求結合起來。

為替代和補充醫學領域的領導者提供的實用建議

行業領導者應優先考慮基於證據的差異化、透明的採購管道、負責任的臨床溝通以及符合監管規定的健康功效聲明，以建立與患者、臨床醫生、監管機構、零售商和數位平台之間的信任。各機構應投資於臨床研究、真實世界數據、安全監測、不利事件報告、從業人員教育以及用於疼痛、壓力、睡眠、肌肉骨骼健康、消化系統健康、免疫支持、女性健康和健康老化等領域的標準化療法方案。

檢驗的基於公共衛生和市場情報的調查方法

本執行摘要採用結構化的二手調查方法編寫，優先考慮檢驗的公共衛生、監管、臨床和市場資訊來源。主要參考文獻包括世界衛生組織 (WHO)、各國衛生機構、同儕審查期刊、監管機構、專業組織、藥典和政府資料集中的資料和指南，涵蓋傳統醫學、補充醫學的使用、產品安全、醫療保健專業人員監管和醫療保健服務取得等方面。

本分析採用“三角測量法”，交叉參考政策趨勢、消費行為指標、從業人員監管規定、臨床證據、數位醫療的普及、地方醫療保健重點以及供應鏈趨勢。結論：信任、證據和整合將塑造未來。

替代和補充醫學正進入一個新階段，其特點是專業化程度的提高、循證醫學的積累、數位技術的應用、品質保證以及與主流醫療保健的選擇性融合。在消費者需求與監管規範、從業人員標準、可信賴的產品、透明的採購管道和可衡量的療效相契合的領域，其發展勢頭最為強勁。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：替代和補充醫學市場：按療法類型分類

  • 生物療法
    • 芳香療法
    • 植物藥
    • 營養補充品
    • 機能性食品及營養保健品
  • 能量療法
    • 針刺
    • 療癒之觸
    • 磁療
    • 靈氣
  • 手法治療和身體療法
    • 脊骨神經醫學療法
    • 拔罐
    • 按摩療法
    • 整骨療法
    • 反射療法
  • 心身醫學
    • 催眠（催眠術）
    • 冥想
    • 放鬆技巧
  • 傳統替代醫學體系
    • 阿育吠陀
    • 同類療法
    • 自然療法
    • 中藥

第8章：替代與補充醫學市場：依疾病適應症分類

  • 癌症支持和安寧療護
  • 心血管健康
  • 糖尿病管理
  • 胃腸道問題
  • 失眠和睡眠障礙
  • 心理健康與憂鬱症
  • 疼痛管理
  • 呼吸系統疾病
  • 皮膚/毛髮疾病
  • 壓力和焦慮症

第9章：替代和補充醫學市場：按最終用戶分類

  • 學術研究機構
  • 居家醫療
  • 醫院和專科診所
  • 私人執業者
  • 健康中心和水療中心

第10章：替代和補充醫學市場：按分銷管道分類

  • 電子商務
  • 線下零售
    • 健康與保健零售店
    • 藥局/藥局

第11章：替代與補充醫學市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：替代和補充醫學市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 替代和補充醫學市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • AmeriCare Physical Therapy by Ivy Rehab
  • AYUSH Ayurvedic Pte Ltd.
  • Baidyanath Group
  • Boiron Laboratories
  • Dabur India Ltd.
  • Dr. Willmar Schwabe India Pvt. Ltd.
  • Emami Limited
  • First Natural Brands Ltd.
  • Full Motion Physical Therapy
  • Gaia Herbs, Inc.
  • Hamdard Laboratories
  • Herb Pharm, LLC
  • Kerala Ayurveda Ltd.
  • Mountain Rose Herbs
  • Nature's Bounty, Inc. by Nestle Health Science
  • Nelson & Co Ltd.
  • Nordic Naturals
  • Patanjali Ayurved Ltd.
  • PEKANA Naturheilmittel GmbH
  • Pharmesis International Ltd.
  • Rocky Mountain Oils LLC
  • SBL Pvt. Ltd.
  • Seirin Corporation
  • Sheng Chang Pharmaceutical Company
  • The Arya Vaidya Pharmacy（CBE）Ltd.
  • The Himalaya Drug Company
  • Tsumura & Co.
  • Vicco Laboratories
  • Wen Ken Group
Product Code: MRR-434CCDA04DB7

The Alternative & Complementary Medicine Market is projected to grow by USD 518.80 billion at a CAGR of 13.33% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 215.95 billion
Estimated Year [2026] USD 244.22 billion
Forecast Year [2032] USD 518.80 billion
CAGR (%) 13.33%

Executive Summary: Alternative & Complementary Medicine Market Outlook

Alternative and complementary medicine is moving from a wellness-adjacent category into a more formal part of preventive health, chronic disease support, pain management, rehabilitation, and mental well-being strategies. Demand is supported by aging populations, rising noncommunicable disease burden, consumer preference for holistic care, and broader acceptance of practices such as acupuncture, chiropractic care, Ayurveda, herbal medicine, naturopathy, meditation, yoga, massage therapy, osteopathy, and traditional Chinese medicine.

The World Health Organization reports that traditional, complementary, and integrative medicine is used in most countries, with many governments developing national policies, practitioner standards, research frameworks, and herbal medicine regulations. For industry leaders, the opportunity is no longer limited to consumer products; it increasingly includes evidence generation, clinical integration, digital delivery, quality assurance, pharmacovigilance, and culturally relevant care models.

Transformative Shifts in the Alternative & Complementary Medicine Landscape

The landscape is being reshaped by evidence-based wellness, patient-centered care, and the convergence of conventional medicine with complementary therapies. Health systems are selectively integrating acupuncture, mindfulness, yoga, chiropractic care, osteopathy, and massage where clinical evidence supports use, particularly for pain, stress, sleep, rehabilitation, musculoskeletal conditions, and quality-of-life improvement.

At the same time, regulators are tightening expectations for product safety, labeling, practitioner credentials, advertising claims, and claims substantiation. This is creating a shift away from fragmented, informal markets toward professionalized services, standardized herbal formulations, transparent sourcing, validated manufacturing practices, and outcome-based partnerships with clinics, insurers, employers, pharmacies, and digital health platforms.

Cumulative Impact of Artificial Intelligence on Complementary Health

Artificial intelligence is becoming a cumulative force across alternative and complementary medicine by improving personalization, evidence discovery, supply chain traceability, quality control, and consumer engagement. AI tools can support symptom triage, lifestyle coaching, treatment adherence, digital therapeutics, practitioner workflows, and pattern recognition across patient-reported outcomes, wearable data, and electronic health records when deployed under appropriate clinical governance.

The greatest impact is emerging in areas that require scale and consistency, including herbal ingredient authentication, contamination screening, adverse event monitoring, practitioner matching, virtual wellness programs, research synthesis, and multilingual consumer education. However, AI adoption must be paired with data privacy, bias mitigation, explainability, clinical validation, human oversight, and clear boundaries between wellness guidance and regulated medical advice.

Key Regional Insights Across Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific remains a foundational region because China, India, Japan, South Korea, Australia, and ASEAN markets combine long-standing medical traditions with expanding digital health infrastructure and formal policy recognition. Traditional Chinese medicine, Ayurveda, Kampo, yoga, acupuncture, herbal products, and mind-body therapies benefit from cultural acceptance, public-sector integration in selected health systems, practitioner education pathways, and export-oriented manufacturing capabilities.

North America is driven by consumer adoption of integrative health, chronic pain management, mental wellness, healthy aging, and employer wellness programs, with the United States and Canada emphasizing evidence, safety, professional credentials, and natural health product oversight. Europe shows structured demand through integrative clinics, pharmacy channels, natural products, osteopathy, homeopathy in selected settings, and strong regulation covering quality, labeling, and safety. Latin America is supported by indigenous and community herbal medicine traditions, expanding private healthcare, and wellness retail, while the Middle East is advancing through premium wellness clinics, preventive health initiatives, medical tourism, and hospitality-linked wellness services. Africa continues to reflect high reliance on traditional medicine in many communities, with growing attention to formal practitioner recognition, botanical quality standards, research capacity, and safe integration with primary healthcare.

Key Group Insights for ASEAN, GCC, European Union, BRICS, G7, and NATO Markets

ASEAN markets are gaining relevance through herbal products, wellness tourism, traditional therapies, digital commerce, and rising middle-class health expenditure, while the GCC is expanding premium wellness clinics, preventive health programs, longevity services, and medical tourism assets aligned with national health transformation agendas. The European Union is shaped by strict product quality, safety documentation, advertising standards, and cross-border regulatory harmonization, which favors organizations with disciplined compliance systems and validated supply chains.

BRICS economies provide scale through large populations, established traditional medicine systems, domestic manufacturing, medicinal plant resources, and growing digital health and e-commerce adoption. G7 markets are attractive for clinically validated services, premium supplements, practitioner-led integrative care, and insurer or employer-linked wellness models that require strong evidence and governance. NATO economies overlap with several high-income healthcare markets where supply chain resilience, cybersecurity, trusted health data infrastructure, and regulatory alignment increasingly influence strategic partnerships in complementary and integrative medicine.

Key Country Insights for Leading Alternative & Complementary Medicine Markets

The United States leads in consumer adoption of complementary health approaches, with National Health Interview Survey data showing broad adult use of yoga, meditation, chiropractic care, massage therapy, naturopathy, and acupuncture. Canada emphasizes regulated natural health products, professional oversight in several provinces, and strong consumer interest in preventive wellness, while Mexico and Brazil combine traditional herbal practices, community-based healing, expanding wellness retail, and private healthcare demand.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support strong demand for natural products, osteopathy, acupuncture, homeopathy in selected channels, herbal medicine, and integrative wellness, while Russia has a sizable herbal and traditional treatment base supported by consumer familiarity with phytotherapy and sanatorium-style wellness traditions. China and India are central to global supply, practice, and knowledge systems through traditional Chinese medicine and Ayurveda, supported by formal education, policy frameworks, and export activity. Japan, Australia, and South Korea add mature consumer markets, high quality expectations, and growing interest in preventive, digital, musculoskeletal, beauty-from-within, stress management, and aging-related care.

Actionable Recommendations for Alternative & Complementary Medicine Leaders

Industry leaders should prioritize evidence-backed differentiation, transparent sourcing, responsible clinical communication, and compliant health claims to build trust with patients, clinicians, regulators, retailers, and digital platforms. Organizations should invest in clinical studies, real-world evidence, safety surveillance, adverse event reporting, practitioner education, and standardized protocols for therapies used in pain, stress, sleep, musculoskeletal health, digestive wellness, immune support, women's health, and healthy aging.

Strategically, organizations should develop omnichannel models that combine clinics, pharmacies, e-commerce, telehealth, mobile apps, and subscription-based wellness programs. Partnerships with hospitals, insurers, employers, universities, accredited practitioner networks, and quality-certified suppliers can improve credibility and access. Leaders should also adopt AI responsibly, strengthen cybersecurity, verify botanical supply chains, monitor contaminants and adulterants, and localize offerings to regional medical traditions, language preferences, cultural expectations, and regulatory frameworks.

Research Methodology Based on Verified Public Health and Market Intelligence

This executive summary is developed using a structured secondary research methodology that prioritizes validated public health, regulatory, clinical, and market intelligence sources. Key references include data and guidance from the World Health Organization, national health agencies, peer-reviewed journals, regulatory authorities, professional associations, pharmacopoeias, and government datasets covering traditional medicine, complementary health use, product safety, practitioner regulation, and healthcare utilization.

The analysis applies triangulation across policy developments, consumer behavior indicators, practitioner regulation, clinical evidence, digital health adoption, regional healthcare priorities, and supply chain dynamics. Conclusion: Credibility, Evidence, and Integration Define the Future

Alternative and complementary medicine is entering a new phase defined by professionalization, evidence generation, digital enablement, quality assurance, and selective integration with mainstream healthcare. Momentum is strongest where consumer demand aligns with regulatory clarity, practitioner standards, trusted products, transparent sourcing, and measurable outcomes.

The next competitive advantage will come from credibility rather than claims volume. Organizations that combine traditional knowledge with scientific validation, responsible AI, compliant communications, safe products, and culturally relevant care models will be best positioned to address demand across preventive health, chronic care support, mental wellness, healthy aging, pain management, and integrative medicine.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Alternative & Complementary Medicine Market, by Therapy Type

  • 7.1. Biologically Based Therapies
    • 7.1.1. Aromatherapy
    • 7.1.2. Botanical Medicine
    • 7.1.3. Dietary Supplements
    • 7.1.4. Functional Food & Nutraceuticals
  • 7.2. Energy therapies
    • 7.2.1. Acupuncture
    • 7.2.2. Healing touch
    • 7.2.3. Magnet therapy
    • 7.2.4. Reiki
  • 7.3. Manipulative & Body-Based Methods
    • 7.3.1. Chiropractic Therapy
    • 7.3.2. Cupping
    • 7.3.3. Massage Therapy
    • 7.3.4. Osteopathic Manipulation
    • 7.3.5. Reflexology
  • 7.4. Mind-Body Medicine
    • 7.4.1. Hypnotherapy (hypnosis)
    • 7.4.2. Meditation
    • 7.4.3. Relaxation Techniques
  • 7.5. Traditional Alternative Medicine Systems
    • 7.5.1. Ayurveda
    • 7.5.2. Homeopathy
    • 7.5.3. Naturopathy
    • 7.5.4. Traditional Chinese medicine

8. Alternative & Complementary Medicine Market, by Disease Indication

  • 8.1. Cancer Support & Palliative Care
  • 8.2. Cardiovascular Health
  • 8.3. Diabetes Management
  • 8.4. Gastrointestinal Issues
  • 8.5. Insomnia & Sleep Disorders
  • 8.6. Mental Health & Depression
  • 8.7. Pain Management
  • 8.8. Respiratory Disorders
  • 8.9. Skin & Hair Disorders
  • 8.10. Stress & Anxiety Disorders

9. Alternative & Complementary Medicine Market, by End-User

  • 9.1. Academic & Research Institutes
  • 9.2. Home Care Settings
  • 9.3. Hospitals & Specialty Clinics
  • 9.4. Individual Practitioners
  • 9.5. Wellness Centers & Spas

10. Alternative & Complementary Medicine Market, by Distribution Channel

  • 10.1. E-commerce
  • 10.2. Offline Retail
    • 10.2.1. Health & Wellness Retail Stores
    • 10.2.2. Pharmacies & Drug Stores

11. Alternative & Complementary Medicine Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Alternative & Complementary Medicine Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Alternative & Complementary Medicine Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. AmeriCare Physical Therapy by Ivy Rehab
  • 15.2. AYUSH Ayurvedic Pte Ltd.
  • 15.3. Baidyanath Group
  • 15.4. Boiron Laboratories
  • 15.5. Dabur India Ltd.
  • 15.6. Dr. Willmar Schwabe India Pvt. Ltd.
  • 15.7. Emami Limited
  • 15.8. First Natural Brands Ltd.
  • 15.9. Full Motion Physical Therapy
  • 15.10. Gaia Herbs, Inc.
  • 15.11. Hamdard Laboratories
  • 15.12. Herb Pharm, LLC
  • 15.13. Kerala Ayurveda Ltd.
  • 15.14. Mountain Rose Herbs
  • 15.15. Nature's Bounty, Inc. by Nestle Health Science
  • 15.16. Nelson & Co Ltd.
  • 15.17. Nordic Naturals
  • 15.18. Patanjali Ayurved Ltd.
  • 15.19. PEKANA Naturheilmittel GmbH
  • 15.20. Pharmesis International Ltd.
  • 15.21. Rocky Mountain Oils LLC
  • 15.22. SBL Pvt. Ltd.
  • 15.23. Seirin Corporation
  • 15.24. Sheng Chang Pharmaceutical Company
  • 15.25. The Arya Vaidya Pharmacy (CBE) Ltd.
  • 15.26. The Himalaya Drug Company
  • 15.27. Tsumura & Co.
  • 15.28. Vicco Laboratories
  • 15.29. Wen Ken Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICALLY BASED THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICALLY BASED THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICALLY BASED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AROMATHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AROMATHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AROMATHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BOTANICAL MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BOTANICAL MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BOTANICAL MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIETARY SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIETARY SUPPLEMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIETARY SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FUNCTIONAL FOOD & NUTRACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FUNCTIONAL FOOD & NUTRACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FUNCTIONAL FOOD & NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENERGY THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENERGY THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENERGY THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ACUPUNCTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ACUPUNCTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACUPUNCTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEALING TOUCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEALING TOUCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEALING TOUCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNET THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNET THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNET THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REIKI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REIKI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REIKI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MANIPULATIVE & BODY-BASED METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MANIPULATIVE & BODY-BASED METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MANIPULATIVE & BODY-BASED METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CHIROPRACTIC THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CHIROPRACTIC THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CHIROPRACTIC THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CUPPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CUPPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CUPPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MASSAGE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MASSAGE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MASSAGE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OSTEOPATHIC MANIPULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OSTEOPATHIC MANIPULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OSTEOPATHIC MANIPULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REFLEXOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REFLEXOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REFLEXOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MIND-BODY MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MIND-BODY MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MIND-BODY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HYPNOTHERAPY (HYPNOSIS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HYPNOTHERAPY (HYPNOSIS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HYPNOTHERAPY (HYPNOSIS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RELAXATION TECHNIQUES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RELAXATION TECHNIQUES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RELAXATION TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AYURVEDA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AYURVEDA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AYURVEDA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOMEOPATHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOMEOPATHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOMEOPATHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NATUROPATHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NATUROPATHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NATUROPATHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TRADITIONAL CHINESE MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TRADITIONAL CHINESE MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TRADITIONAL CHINESE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CANCER SUPPORT & PALLIATIVE CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CANCER SUPPORT & PALLIATIVE CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CANCER SUPPORT & PALLIATIVE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CARDIOVASCULAR HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIOVASCULAR HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CARDIOVASCULAR HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL ISSUES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL ISSUES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL ISSUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INSOMNIA & SLEEP DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INSOMNIA & SLEEP DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INSOMNIA & SLEEP DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MENTAL HEALTH & DEPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MENTAL HEALTH & DEPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MENTAL HEALTH & DEPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SKIN & HAIR DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SKIN & HAIR DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SKIN & HAIR DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL STRESS & ANXIETY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL STRESS & ANXIETY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL STRESS & ANXIETY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOSPITALS & SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INDIVIDUAL PRACTITIONERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL INDIVIDUAL PRACTITIONERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INDIVIDUAL PRACTITIONERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL WELLNESS CENTERS & SPAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL WELLNESS CENTERS & SPAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL WELLNESS CENTERS & SPAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL E-COMMERCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL E-COMMERCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL E-COMMERCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL OFFLINE RETAIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL OFFLINE RETAIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL OFFLINE RETAIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HEALTH & WELLNESS RETAIL STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEALTH & WELLNESS RETAIL STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HEALTH & WELLNESS RETAIL STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACIES & DRUG STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PHARMACIES & DRUG STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACIES & DRUG STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 217. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 220. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 224. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 225. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 226. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 250. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 253. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 258. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 259. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. G7 ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 261. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 264. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 265. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 269. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 270. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. NATO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 301. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 305. MEXICO ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL ALTERNATIVE